id	sid	tid	token	lemma	pos
ct-10015	1	1	2018	2018	NUM
ct-10015	1	2	:	:	PUNCT
ct-10015	1	3	pharmacokinetics	pharmacokinetic	NOUN
ct-10015	1	4	of	of	ADP
ct-10015	1	5	intra	intra	ADJ
ct-10015	1	6	-	-	ADJ
ct-10015	1	7	rectal	rectal	ADJ
ct-10015	1	8	altrenogest	altrenog	ADJ
ct-10015	1	9	administration	administration	NOUN
ct-10015	1	10	in	in	ADP
ct-10015	1	11	horses	horse	NOUN
ct-10015	1	12	pharmacokinetics	pharmacokinetic	NOUN
ct-10015	1	13	of	of	ADP
ct-10015	1	14	intra	intra	ADJ
ct-10015	1	15	-	-	ADJ
ct-10015	1	16	rectal	rectal	ADJ
ct-10015	1	17	altrenogest	altrenog	ADJ
ct-10015	1	18	administration	administration	NOUN
ct-10015	1	19	in	in	ADP
ct-10015	1	20	horses	horses	PROPN
ct-10015	1	21	k.e	k.e	PROPN
ct-10015	1	22	.	.	PROPN
ct-10015	1	23	ellis	ellis	PROPN
ct-10015	1	24	,	,	PUNCT
ct-10015	1	25	a	a	DET
ct-10015	1	26	k.a.von	k.a.von	PROPN
ct-10015	1	27	dollen	dollen	NOUN
ct-10015	1	28	,	,	PUNCT
ct-10015	1	29	a	a	DET
ct-10015	1	30	k.	k.	PROPN
ct-10015	1	31	mirandi	mirandi	PROPN
ct-10015	1	32	,	,	PUNCT
ct-10015	1	33	a	a	DET
ct-10015	1	34	t.m	t.m	PROPN
ct-10015	1	35	.	.	PROPN
ct-10015	1	36	beachler	beachler	PROPN
ct-10015	1	37	,	,	PUNCT
ct-10015	1	38	a	a	DET
ct-10015	1	39	c.s	c.s	PROPN
ct-10015	1	40	.	.	PROPN
ct-10015	1	41	bailey	bailey	PROPN
ct-10015	1	42	,	,	PUNCT
ct-10015	1	43	a	a	DET
ct-10015	1	44	j.l	j.l	PROPN
ct-10015	1	45	.	.	PROPN
ct-10015	1	46	davis	davis	PROPN
ct-10015	1	47	,	,	PUNCT
ct-10015	1	48	b	b	PROPN
ct-10015	1	49	s.k	s.k	PROPN
ct-10015	1	50	.	.	PROPN
ct-10015	1	51	lylea	lylea	PROPN
ct-10015	1	52	adepartment	adepartment	NOUN
ct-10015	1	53	of	of	ADP
ct-10015	1	54	clinical	clinical	ADJ
ct-10015	1	55	sciences	science	NOUN
ct-10015	1	56	,	,	PUNCT
ct-10015	1	57	college	college	NOUN
ct-10015	1	58	of	of	ADP
ct-10015	1	59	veterinary	veterinary	ADJ
ct-10015	1	60	medicine	medicine	NOUN
ct-10015	1	61	,	,	PUNCT
ct-10015	1	62	north	north	PROPN
ct-10015	1	63	carolina	carolina	PROPN
ct-10015	1	64	state	state	PROPN
ct-10015	1	65	university	university	PROPN
ct-10015	1	66	,	,	PUNCT
ct-10015	1	67	raleigh	raleigh	PROPN
ct-10015	1	68	,	,	PUNCT
ct-10015	1	69	nc	nc	PROPN
ct-10015	1	70	bdepartment	bdepartment	PROPN
ct-10015	1	71	of	of	ADP
ct-10015	1	72	biomedical	biomedical	ADJ
ct-10015	1	73	sciences	science	NOUN
ct-10015	1	74	and	and	CCONJ
ct-10015	1	75	pathobiology	pathobiology	NOUN
ct-10015	1	76	,	,	PUNCT
ct-10015	1	77	virginia	virginia	PROPN
ct-10015	1	78	-	-	PUNCT
ct-10015	1	79	maryland	maryland	PROPN
ct-10015	1	80	college	college	NOUN
ct-10015	1	81	of	of	ADP
ct-10015	1	82	veterinary	veterinary	ADJ
ct-10015	1	83	medicine	medicine	NOUN
ct-10015	1	84	,	,	PUNCT
ct-10015	1	85	blacksburg	blacksburg	PROPN
ct-10015	1	86	,	,	PUNCT
ct-10015	1	87	va	va	PROPN
ct-10015	1	88	hospitalized	hospitalize	VERB
ct-10015	1	89	high	high	ADJ
ct-10015	1	90	-	-	PUNCT
ct-10015	1	91	risk	risk	NOUN
ct-10015	1	92	pregnant	pregnant	ADJ
ct-10015	1	93	mares	mare	NOUN
ct-10015	1	94	being	be	AUX
ct-10015	1	95	held	hold	VERB
ct-10015	1	96	nil	nil	NOUN
ct-10015	1	97	per	per	ADP
ct-10015	1	98	os	os	NOUN
ct-10015	1	99	(	(	PUNCT
ct-10015	1	100	npo	npo	PROPN
ct-10015	1	101	)	)	PUNCT
ct-10015	1	102	due	due	ADP
ct-10015	1	103	to	to	ADP
ct-10015	1	104	medical	medical	ADJ
ct-10015	1	105	or	or	CCONJ
ct-10015	1	106	surgical	surgical	ADJ
ct-10015	1	107	events	event	NOUN
ct-10015	1	108	present	present	VERB
ct-10015	1	109	a	a	DET
ct-10015	1	110	dilemma	dilemma	NOUN
ct-10015	1	111	for	for	ADP
ct-10015	1	112	multi	multi	ADJ
ct-10015	1	113	-	-	ADJ
ct-10015	1	114	modal	modal	ADJ
ct-10015	1	115	therapy	therapy	NOUN
ct-10015	1	116	aimed	aim	VERB
ct-10015	1	117	at	at	ADP
ct-10015	1	118	pregnancy	pregnancy	NOUN
ct-10015	1	119	maintenance	maintenance	NOUN
ct-10015	1	120	,	,	PUNCT
ct-10015	1	121	which	which	PRON
ct-10015	1	122	commonly	commonly	ADV
ct-10015	1	123	includes	include	VERB
ct-10015	1	124	oral	oral	ADJ
ct-10015	1	125	altrenogest	altrenogest	NOUN
ct-10015	1	126	as	as	ADP
ct-10015	1	127	the	the	DET
ct-10015	1	128	supplemented	supplement	VERB
ct-10015	1	129	progestin	progestin	NOUN
ct-10015	1	130	.	.	PUNCT
ct-10015	2	1	some	some	DET
ct-10015	2	2	long	long	ADV
ct-10015	2	3	-	-	PUNCT
ct-10015	2	4	acting	act	VERB
ct-10015	2	5	intramuscular	intramuscular	ADJ
ct-10015	2	6	preparations	preparation	NOUN
ct-10015	2	7	do	do	AUX
ct-10015	2	8	not	not	PART
ct-10015	2	9	reach	reach	VERB
ct-10015	2	10	peak	peak	NOUN
ct-10015	2	11	concentrations	concentration	NOUN
ct-10015	2	12	until	until	ADP
ct-10015	2	13	24	24	NUM
ct-10015	2	14	h	h	NOUN
ct-10015	2	15	after	after	ADP
ct-10015	2	16	administration	administration	NOUN
ct-10015	2	17	and	and	CCONJ
ct-10015	2	18	repeated	repeat	VERB
ct-10015	2	19	i	i	PROPN
ct-10015	2	20	m	m	VERB
ct-10015	2	21	injections	injection	NOUN
ct-10015	2	22	can	can	AUX
ct-10015	2	23	cause	cause	VERB
ct-10015	2	24	severe	severe	ADJ
ct-10015	2	25	complications	complication	NOUN
ct-10015	2	26	,	,	PUNCT
ct-10015	2	27	such	such	ADJ
ct-10015	2	28	as	as	ADP
ct-10015	2	29	abscess	abscess	ADJ
ct-10015	2	30	formation	formation	NOUN
ct-10015	2	31	and	and	CCONJ
ct-10015	2	32	clostridial	clostridial	ADJ
ct-10015	2	33	myonecrosis	myonecrosis	NOUN
ct-10015	2	34	.	.	PUNCT
ct-10015	3	1	rectal	rectal	ADJ
ct-10015	3	2	administration	administration	NOUN
ct-10015	3	3	of	of	ADP
ct-10015	3	4	medications	medication	NOUN
ct-10015	3	5	is	be	AUX
ct-10015	3	6	a	a	DET
ct-10015	3	7	recognized	recognize	VERB
ct-10015	3	8	route	route	NOUN
ct-10015	3	9	for	for	ADP
ct-10015	3	10	achieving	achieve	VERB
ct-10015	3	11	systemic	systemic	ADJ
ct-10015	3	12	concentrations	concentration	NOUN
ct-10015	3	13	,	,	PUNCT
ct-10015	3	14	but	but	CCONJ
ct-10015	3	15	there	there	PRON
ct-10015	3	16	are	be	VERB
ct-10015	3	17	currently	currently	ADV
ct-10015	3	18	no	no	DET
ct-10015	3	19	data	datum	NOUN
ct-10015	3	20	available	available	ADJ
ct-10015	3	21	on	on	ADP
ct-10015	3	22	the	the	DET
ct-10015	3	23	pharmacokinetics	pharmacokinetic	NOUN
ct-10015	3	24	of	of	ADP
ct-10015	3	25	rectal	rectal	ADJ
ct-10015	3	26	altrenogest	altrenogest	PROPN
ct-10015	3	27	administration	administration	NOUN
ct-10015	3	28	in	in	ADP
ct-10015	3	29	horses	horse	NOUN
ct-10015	3	30	.	.	PUNCT
ct-10015	4	1	the	the	DET
ct-10015	4	2	purpose	purpose	NOUN
ct-10015	4	3	of	of	ADP
ct-10015	4	4	this	this	DET
ct-10015	4	5	study	study	NOUN
ct-10015	4	6	was	be	AUX
ct-10015	4	7	to	to	PART
ct-10015	4	8	determine	determine	VERB
ct-10015	4	9	the	the	DET
ct-10015	4	10	pharmacokinetics	pharmacokinetic	NOUN
ct-10015	4	11	of	of	ADP
ct-10015	4	12	altrenogest	altrenogest	NOUN
ct-10015	4	13	following	follow	VERB
ct-10015	4	14	per	per	ADP
ct-10015	4	15	os	os	NOUN
ct-10015	4	16	(	(	PUNCT
ct-10015	4	17	po	po	NOUN
ct-10015	4	18	)	)	PUNCT
ct-10015	4	19	or	or	CCONJ
ct-10015	4	20	per	per	ADP
ct-10015	4	21	rectum	rectum	NOUN
ct-10015	4	22	(	(	PUNCT
ct-10015	4	23	pr	pr	NOUN
ct-10015	4	24	)	)	PUNCT
ct-10015	4	25	administration	administration	NOUN
ct-10015	4	26	in	in	ADP
ct-10015	4	27	mares	mare	NOUN
ct-10015	4	28	.	.	PUNCT
ct-10015	5	1	using	use	VERB
ct-10015	5	2	a	a	DET
ct-10015	5	3	randomized	randomized	ADJ
ct-10015	5	4	two	two	NUM
ct-10015	5	5	-	-	PUNCT
ct-10015	5	6	way	way	NOUN
ct-10015	5	7	crossover	crossover	NOUN
ct-10015	5	8	study	study	NOUN
ct-10015	5	9	design	design	NOUN
ct-10015	5	10	,	,	PUNCT
ct-10015	5	11	six	six	NUM
ct-10015	5	12	horses	horse	NOUN
ct-10015	5	13	received	receive	VERB
ct-10015	5	14	altrenogest	altrenogest	NOUN
ct-10015	5	15	(	(	PUNCT
ct-10015	5	16	0.088	0.088	NUM
ct-10015	5	17	mg	mg	PROPN
ct-10015	5	18	/	/	SYM
ct-10015	5	19	kg	kg	PROPN
ct-10015	5	20	;	;	PUNCT
ct-10015	5	21	po	po	NOUN
ct-10015	5	22	or	or	CCONJ
ct-10015	5	23	pr	pr	ADJ
ct-10015	5	24	q	q	PROPN
ct-10015	5	25	24	24	NUM
ct-10015	5	26	h	h	NOUN
ct-10015	5	27	for	for	ADP
ct-10015	5	28	5	5	NUM
ct-10015	5	29	d	d	NOUN
ct-10015	5	30	)	)	PUNCT
ct-10015	5	31	,	,	PUNCT
ct-10015	5	32	with	with	ADP
ct-10015	5	33	a	a	DET
ct-10015	5	34	7day	7day	PROPN
ct-10015	5	35	washout	washout	NOUN
ct-10015	5	36	period	period	NOUN
ct-10015	5	37	.	.	PUNCT
ct-10015	6	1	plasma	plasma	NOUN
ct-10015	6	2	samples	sample	NOUN
ct-10015	6	3	were	be	AUX
ct-10015	6	4	collected	collect	VERB
ct-10015	6	5	prior	prior	ADV
ct-10015	6	6	to	to	ADP
ct-10015	6	7	administration	administration	NOUN
ct-10015	6	8	(	(	PUNCT
ct-10015	6	9	0	0	NUM
ct-10015	6	10	h	h	NOUN
ct-10015	6	11	)	)	PUNCT
ct-10015	6	12	and	and	CCONJ
ct-10015	6	13	at	at	ADP
ct-10015	6	14	0.25	0.25	NUM
ct-10015	6	15	,	,	PUNCT
ct-10015	6	16	0.5	0.5	NUM
ct-10015	6	17	,	,	PUNCT
ct-10015	6	18	1.0	1.0	NUM
ct-10015	6	19	,	,	PUNCT
ct-10015	6	20	1.5	1.5	NUM
ct-10015	6	21	,	,	PUNCT
ct-10015	6	22	2.0	2.0	NUM
ct-10015	6	23	,	,	PUNCT
ct-10015	6	24	2.5	2.5	NUM
ct-10015	6	25	,	,	PUNCT
ct-10015	6	26	3.0	3.0	NUM
ct-10015	6	27	,	,	PUNCT
ct-10015	6	28	4.0	4.0	NUM
ct-10015	6	29	,	,	PUNCT
ct-10015	6	30	6.0	6.0	NUM
ct-10015	6	31	,	,	PUNCT
ct-10015	6	32	8.0	8.0	NUM
ct-10015	6	33	,	,	PUNCT
ct-10015	6	34	12	12	NUM
ct-10015	6	35	,	,	PUNCT
ct-10015	6	36	24	24	NUM
ct-10015	6	37	,	,	PUNCT
ct-10015	6	38	48	48	NUM
ct-10015	6	39	,	,	PUNCT
ct-10015	6	40	72	72	NUM
ct-10015	6	41	,	,	PUNCT
ct-10015	6	42	96.0	96.0	NUM
ct-10015	6	43	,	,	PUNCT
ct-10015	6	44	96.25	96.25	NUM
ct-10015	6	45	,	,	PUNCT
ct-10015	6	46	96.5	96.5	NUM
ct-10015	6	47	,	,	PUNCT
ct-10015	6	48	97.0	97.0	NUM
ct-10015	6	49	,	,	PUNCT
ct-10015	6	50	97.5	97.5	NUM
ct-10015	6	51	,	,	PUNCT
ct-10015	6	52	98.0	98.0	NUM
ct-10015	6	53	,	,	PUNCT
ct-10015	6	54	98.5	98.5	NUM
ct-10015	6	55	,	,	PUNCT
ct-10015	6	56	99.0	99.0	NUM
ct-10015	6	57	,	,	PUNCT
ct-10015	6	58	100	100	NUM
ct-10015	6	59	,	,	PUNCT
ct-10015	6	60	102	102	NUM
ct-10015	6	61	,	,	PUNCT
ct-10015	6	62	104	104	NUM
ct-10015	6	63	,	,	PUNCT
ct-10015	6	64	108	108	NUM
ct-10015	6	65	,	,	PUNCT
ct-10015	6	66	112	112	NUM
ct-10015	6	67	,	,	PUNCT
ct-10015	6	68	120	120	NUM
ct-10015	6	69	,	,	PUNCT
ct-10015	6	70	144	144	NUM
ct-10015	6	71	,	,	PUNCT
ct-10015	6	72	168	168	NUM
ct-10015	6	73	,	,	PUNCT
ct-10015	6	74	and	and	CCONJ
ct-10015	6	75	192	192	NUM
ct-10015	6	76	h	h	NOUN
ct-10015	6	77	after	after	ADP
ct-10015	6	78	administration	administration	NOUN
ct-10015	6	79	.	.	PUNCT
ct-10015	7	1	the	the	DET
ct-10015	7	2	concentrations	concentration	NOUN
ct-10015	7	3	of	of	ADP
ct-10015	7	4	altrenogest	altrenog	ADJ
ct-10015	7	5	were	be	AUX
ct-10015	7	6	determined	determine	VERB
ct-10015	7	7	by	by	ADP
ct-10015	7	8	ultra	ultra	ADJ
ct-10015	7	9	-	-	ADJ
ct-10015	7	10	high	high	ADJ
ct-10015	7	11	performance	performance	NOUN
ct-10015	7	12	liquid	liquid	NOUN
ct-10015	7	13	chromatography	chromatography	NOUN
ct-10015	7	14	with	with	ADP
ct-10015	7	15	tandem	tandem	PROPN
ct-10015	7	16	mass	mass	PROPN
ct-10015	7	17	spectrometry	spectrometry	NOUN
ct-10015	7	18	.	.	PUNCT
ct-10015	8	1	assay	assay	PROPN
ct-10015	8	2	validation	validation	NOUN
ct-10015	8	3	and	and	CCONJ
ct-10015	8	4	quality	quality	NOUN
ct-10015	8	5	assurance	assurance	NOUN
ct-10015	8	6	were	be	AUX
ct-10015	8	7	performed	perform	VERB
ct-10015	8	8	according	accord	VERB
ct-10015	8	9	to	to	ADP
ct-10015	8	10	published	publish	VERB
ct-10015	8	11	guidelines	guideline	NOUN
ct-10015	8	12	.	.	PUNCT
ct-10015	9	1	administration	administration	NOUN
ct-10015	9	2	pr	pr	PROPN
ct-10015	9	3	produced	produce	VERB
ct-10015	9	4	therapeutic	therapeutic	ADJ
ct-10015	9	5	plasma	plasma	NOUN
ct-10015	9	6	levels	level	NOUN
ct-10015	9	7	in	in	ADP
ct-10015	9	8	all	all	DET
ct-10015	9	9	mares	mare	NOUN
ct-10015	9	10	following	follow	VERB
ct-10015	9	11	initial	initial	ADJ
ct-10015	9	12	dosing	dosing	NOUN
ct-10015	9	13	(	(	PUNCT
ct-10015	9	14	cmax	cmax	NOUN
ct-10015	9	15	2.54	2.54	NUM
ct-10015	9	16	+	+	NUM
ct-10015	9	17	1.18	1.18	NUM
ct-10015	9	18	ng	ng	PROPN
ct-10015	9	19	/	/	SYM
ct-10015	9	20	ml	ml	NOUN
ct-10015	9	21	)	)	PUNCT
ct-10015	9	22	with	with	ADP
ct-10015	9	23	a	a	DET
ct-10015	9	24	markedly	markedly	ADV
ct-10015	9	25	decreased	decrease	VERB
ct-10015	9	26	time	time	NOUN
ct-10015	9	27	to	to	ADP
ct-10015	9	28	maximum	maximum	ADJ
ct-10015	9	29	concentration	concentration	NOUN
ct-10015	9	30	(	(	PUNCT
ct-10015	9	31	tmax	tmax	ADP
ct-10015	9	32	0.83	0.83	NUM
ct-10015	9	33	+	+	CCONJ
ct-10015	9	34	0.26	0.26	NUM
ct-10015	9	35	h	h	NOUN
ct-10015	9	36	)	)	PUNCT
ct-10015	9	37	when	when	SCONJ
ct-10015	9	38	compared	compare	VERB
ct-10015	9	39	to	to	ADP
ct-10015	9	40	po	po	PROPN
ct-10015	9	41	administration	administration	PROPN
ct-10015	9	42	(	(	PUNCT
ct-10015	9	43	tmax	tmax	ADP
ct-10015	9	44	4.25	4.25	NUM
ct-10015	9	45	+	+	NOUN
ct-10015	9	46	4.83	4.83	NUM
ct-10015	9	47	h	h	NOUN
ct-10015	9	48	)	)	PUNCT
ct-10015	9	49	.	.	PUNCT
ct-10015	10	1	plasma	plasma	NOUN
ct-10015	10	2	concentrations	concentration	NOUN
ct-10015	10	3	only	only	ADV
ct-10015	10	4	persisted	persist	VERB
ct-10015	10	5	above	above	ADP
ct-10015	10	6	presumed	presume	VERB
ct-10015	10	7	therapeutic	therapeutic	ADJ
ct-10015	10	8	concentrations	concentration	NOUN
ct-10015	10	9	(	(	PUNCT
ct-10015	10	10	0.5	0.5	NUM
ct-10015	10	11	ng	ng	NOUN
ct-10015	10	12	/	/	SYM
ct-10015	10	13	ml	ml	NOUN
ct-10015	10	14	)	)	PUNCT
ct-10015	10	15	for	for	ADP
ct-10015	10	16	a	a	DET
ct-10015	10	17	mean	mean	NOUN
ct-10015	10	18	of	of	ADP
ct-10015	10	19	5.5	5.5	NUM
ct-10015	10	20	h	h	NOUN
ct-10015	10	21	(	(	PUNCT
ct-10015	10	22	range	range	NOUN
ct-10015	10	23	3	3	NUM
ct-10015	10	24	-	-	SYM
ct-10015	10	25	8	8	NUM
ct-10015	10	26	h	h	NOUN
ct-10015	10	27	)	)	PUNCT
ct-10015	10	28	following	follow	VERB
ct-10015	10	29	pr	pr	NOUN
ct-10015	10	30	administration	administration	NOUN
ct-10015	10	31	,	,	PUNCT
ct-10015	10	32	while	while	SCONJ
ct-10015	10	33	serum	serum	NOUN
ct-10015	10	34	concentrations	concentration	NOUN
ct-10015	10	35	remained	remain	VERB
ct-10015	10	36	>	>	X
ct-10015	10	37	0.5	0.5	NUM
ct-10015	10	38	ng	ng	PROPN
ct-10015	10	39	/	/	SYM
ct-10015	10	40	ml	ml	X
ct-10015	10	41	for	for	ADP
ct-10015	10	42	at	at	ADV
ct-10015	10	43	least	least	ADJ
ct-10015	10	44	24	24	NUM
ct-10015	10	45	h	h	NOUN
ct-10015	10	46	in	in	ADP
ct-10015	10	47	all	all	DET
ct-10015	10	48	horses	horse	NOUN
ct-10015	10	49	following	follow	VERB
ct-10015	10	50	po	po	PROPN
ct-10015	10	51	administration	administration	PROPN
ct-10015	10	52	.	.	PUNCT
ct-10015	11	1	the	the	DET
ct-10015	11	2	calculated	calculated	ADJ
ct-10015	11	3	half	half	ADJ
ct-10015	11	4	-	-	PUNCT
ct-10015	11	5	life	life	NOUN
ct-10015	11	6	(	(	PUNCT
ct-10015	11	7	t½	t½	NOUN
ct-10015	11	8	)	)	PUNCT
ct-10015	11	9	of	of	ADP
ct-10015	11	10	pr	pr	NOUN
ct-10015	11	11	administration	administration	NOUN
ct-10015	11	12	(	(	PUNCT
ct-10015	11	13	2.82	2.82	NUM
ct-10015	11	14	+	+	NUM
ct-10015	11	15	1.07	1.07	NUM
ct-10015	11	16	h	h	NOUN
ct-10015	11	17	)	)	PUNCT
ct-10015	11	18	was	be	AUX
ct-10015	11	19	correspondingly	correspondingly	ADV
ct-10015	11	20	decreased	decrease	VERB
ct-10015	11	21	when	when	SCONJ
ct-10015	11	22	compared	compare	VERB
ct-10015	11	23	to	to	ADP
ct-10015	11	24	po	po	PROPN
ct-10015	11	25	administration	administration	PROPN
ct-10015	11	26	(	(	PUNCT
ct-10015	11	27	7.01	7.01	NUM
ct-10015	11	28	+	+	NUM
ct-10015	11	29	3.13	3.13	NUM
ct-10015	11	30	h	h	NOUN
ct-10015	11	31	)	)	PUNCT
ct-10015	11	32	.	.	PUNCT
ct-10015	12	1	relative	relative	ADJ
ct-10015	12	2	bioavailability	bioavailability	NOUN
ct-10015	12	3	of	of	ADP
ct-10015	12	4	altrenogest	altrenogest	NOUN
ct-10015	12	5	following	follow	VERB
ct-10015	12	6	pr	pr	ADP
ct-10015	12	7	administration	administration	NOUN
ct-10015	12	8	was	be	AUX
ct-10015	12	9	only	only	ADV
ct-10015	12	10	5.47	5.47	NUM
ct-10015	12	11	%	%	NOUN
ct-10015	12	12	.	.	PUNCT
ct-10015	13	1	in	in	ADP
ct-10015	13	2	conclusion	conclusion	NOUN
ct-10015	13	3	,	,	PUNCT
ct-10015	13	4	altrenogest	altrenogest	PROPN
ct-10015	13	5	is	be	AUX
ct-10015	13	6	rapidly	rapidly	ADV
ct-10015	13	7	absorbed	absorb	VERB
ct-10015	13	8	following	follow	VERB
ct-10015	13	9	pr	pr	NOUN
ct-10015	13	10	administration	administration	NOUN
ct-10015	13	11	in	in	ADP
ct-10015	13	12	the	the	DET
ct-10015	13	13	horse	horse	NOUN
ct-10015	13	14	and	and	CCONJ
ct-10015	13	15	reaches	reach	VERB
ct-10015	13	16	therapeutic	therapeutic	ADJ
ct-10015	13	17	concentrations	concentration	NOUN
ct-10015	13	18	,	,	PUNCT
ct-10015	13	19	making	make	VERB
ct-10015	13	20	this	this	PRON
ct-10015	13	21	a	a	DET
ct-10015	13	22	viable	viable	ADJ
ct-10015	13	23	method	method	NOUN
ct-10015	13	24	of	of	ADP
ct-10015	13	25	treatment	treatment	NOUN
ct-10015	13	26	in	in	ADP
ct-10015	13	27	npo	npo	PROPN
ct-10015	13	28	mares	mare	NOUN
ct-10015	13	29	.	.	PUNCT
ct-10015	14	1	however	however	ADV
ct-10015	14	2	,	,	PUNCT
ct-10015	14	3	the	the	DET
ct-10015	14	4	decreased	decrease	VERB
ct-10015	14	5	bioavailability	bioavailability	NOUN
ct-10015	14	6	and	and	CCONJ
ct-10015	14	7	shorter	short	ADJ
ct-10015	14	8	detection	detection	NOUN
ct-10015	14	9	time	time	NOUN
ct-10015	14	10	would	would	AUX
ct-10015	14	11	require	require	VERB
ct-10015	14	12	a	a	DET
ct-10015	14	13	shorter	short	ADJ
ct-10015	14	14	dosing	dosing	NOUN
ct-10015	14	15	interval	interval	NOUN
ct-10015	14	16	.	.	PUNCT
ct-10015	15	1	results	result	NOUN
ct-10015	15	2	of	of	ADP
ct-10015	15	3	this	this	DET
ct-10015	15	4	study	study	NOUN
ct-10015	15	5	suggest	suggest	VERB
ct-10015	15	6	0.088	0.088	NUM
ct-10015	15	7	mg	mg	PROPN
ct-10015	15	8	/	/	SYM
ct-10015	15	9	kg	kg	PROPN
ct-10015	15	10	pr	pr	INTJ
ct-10015	15	11	q	q	NOUN
ct-10015	15	12	4	4	NUM
ct-10015	15	13	-	-	SYM
ct-10015	15	14	8	8	NUM
ct-10015	15	15	h	h	NOUN
ct-10015	15	16	would	would	AUX
ct-10015	15	17	be	be	AUX
ct-10015	15	18	necessary	necessary	ADJ
ct-10015	15	19	to	to	PART
ct-10015	15	20	maintain	maintain	VERB
ct-10015	15	21	therapeutic	therapeutic	ADJ
ct-10015	15	22	concentrations	concentration	NOUN
ct-10015	15	23	over	over	ADP
ct-10015	15	24	a	a	DET
ct-10015	15	25	24	24	NUM
ct-10015	15	26	h	h	NOUN
ct-10015	15	27	period	period	NOUN
ct-10015	15	28	.	.	PUNCT
ct-10015	16	1	keywords	keyword	NOUN
ct-10015	16	2	:	:	PUNCT
ct-10015	16	3	horse	horse	NOUN
ct-10015	16	4	,	,	PUNCT
ct-10015	16	5	altrenogest	altrenogest	ADV
ct-10015	16	6	,	,	PUNCT
ct-10015	16	7	pharmacokinetics	pharmacokinetic	NOUN
ct-10015	16	8	,	,	PUNCT
ct-10015	16	9	intra	intra	ADJ
ct-10015	16	10	-	-	ADJ
ct-10015	16	11	rectal	rectal	ADJ
ct-10015	16	12	administration	administration	NOUN
ct-10015	16	13	clinical	clinical	ADJ
ct-10015	16	14	theriogenology	theriogenology	NOUN
ct-10015	16	15	•	•	NOUN
ct-10015	16	16	volume	volume	NOUN
ct-10015	16	17	10	10	NUM
ct-10015	16	18	,	,	PUNCT
ct-10015	16	19	number	number	NOUN
ct-10015	16	20	3	3	NUM
ct-10015	16	21	•	•	NUM
ct-10015	16	22	september	september	PROPN
ct-10015	16	23	2018313	2018313	NUM